Sarah Bahraoui

ORCID: 0000-0002-7928-4063
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mesenchymal stem cell research
  • Osteoarthritis Treatment and Mechanisms
  • Cardiac Ischemia and Reperfusion
  • Periodontal Regeneration and Treatments
  • Tissue Engineering and Regenerative Medicine
  • Electrospun Nanofibers in Biomedical Applications
  • T-cell and B-cell Immunology
  • Cancer, Hypoxia, and Metabolism
  • Cancer-related molecular mechanisms research
  • biodegradable polymer synthesis and properties
  • Bone health and treatments
  • Cardiac Fibrosis and Remodeling
  • CAR-T cell therapy research
  • Bone fractures and treatments
  • Adipose Tissue and Metabolism
  • Cardiac Structural Anomalies and Repair
  • Congenital heart defects research

Université de Montpellier
2021-2024

Laboratoire d'études sur les monothéismes
2024

Hôpital Saint Eloi
2024

Inserm
2021-2024

Institute for Regenerative Medicine & Biotherapy
2019-2022

Mesenchymal Stromal Cells (MSC) have been widely used for their therapeutic properties in many clinical applications including myocardial infarction. Despite promising preclinical results and evidences of safety efficacy phases I/ II, inconsistencies phase III trials reported. In a previous study, we shown using MSC derived from the bone marrow PPARβ/δ (Peroxisome proliferator-activated receptors β/δ) knockout mice that acute cardioprotective during first hour reperfusion are...

10.1186/s13287-022-02840-0 article EN cc-by Stem Cell Research & Therapy 2022-04-23

Initially discovered for its ability to regenerate ear holes, the Murphy Roth Large (MRL) mouse has been subject of multiple research studies aimed at evaluating other body tissues and deciphering mechanisms underlying it. These enhanced abilities regenerate, retained during adulthood, protect MRL from degenerative diseases such as osteoarthritis (OA). Here, we hypothesized that mesenchymal stromal/stem cells (MSC) derived regenerative could be involved in their potential through release...

10.1186/s13287-024-03650-2 article EN cc-by Stem Cell Research & Therapy 2024-03-07

Objective: Cartilage, as the majority of adult mammalian tissues, has limited regeneration capacity. Cartilage degradation consecutive to joint injury or aging then leads irreversible damage and diseases. In contrast, several vertebrate species such zebrafish have remarkable capacity spontaneously regenerate skeletal structures after severe injuries. The objective our study was test regenerative Meckel’s cartilage (MC) upon mechanical in identify mechanisms underlying this process. Methods...

10.3389/fcell.2023.1123299 article EN cc-by Frontiers in Cell and Developmental Biology 2023-04-04

Abstract Background: Initially discovered for its ability to regenerate ear holes, the MRL mouse has been subject of multiple research studies aimed at evaluating other body tissues and deciphering mechanisms underlying it. These enhanced abilities regenerate, retained in adult, protect from degenerative diseases such as osteoarthritis (OA). Here, we hypothesized that MSC derived regenerative could be involved their potential through release pro-regenerative mediators. Method: To address...

10.21203/rs.3.rs-2733110/v1 preprint EN cc-by Research Square (Research Square) 2023-04-04

Abstract Background Initially discovered for its ability to regenerate ear holes, the MRL mouse has been subject of multiple research studies aimed at evaluating other body tissues and deciphering mechanisms underlying it. These enhanced abilities regenerate, retained in adult, protect from degenerative diseases such as osteoarthritis (OA). Here, we hypothesized that MSC derived regenerative could be involved their potential through release pro-regenerative mediators. Method To address this...

10.1101/2023.01.18.524662 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-01-19

Abstract Background: Mesenchymal Stromal Cells (MSC) have been widely used for their therapeutic properties in many clinical applications including myocardial infarction. Despite promising preclinical results and evidences of safety efficacy phases I/ II, inconsistencies phase III trials reported. In a previous study, we shown using MSC derived from the bone marrow PPARβ/δ (Peroxisome proliferator-activated receptors β/δ) knockout mice that acute cardioprotective during first hour...

10.21203/rs.3.rs-1139048/v1 preprint EN cc-by Research Square (Research Square) 2021-12-09
Coming Soon ...